• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防肾脏疾病的发生和进展。

Prevention of the development and progression of renal disease.

作者信息

Hostetter Thomas H

机构信息

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Bethesda, Maryland, USA.

出版信息

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S144-7. doi: 10.1097/01.asn.0000070150.60928.06.

DOI:10.1097/01.asn.0000070150.60928.06
PMID:12819320
Abstract

Prevention of the major causes of ESRD, hypertension, and diabetes, is possible. Careful glycemic control can prevent diabetes nephropathy. BP control can likely prevent the large majority of hypertensive renal disease. Testing for diabetic renal disease is well founded. In contrast, screening for hypertensive kidney disease is less well defined. Most established renal disease can be treated with glycemic control in the case of diabetes, BP treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and dietary protein restriction. Other therapeutic targets have been proposed, but are not well established. Future research should focus on defining the high risk patients, developing better markers of risk, and designing additional therapies.

摘要

预防终末期肾病(ESRD)的主要病因——高血压和糖尿病是有可能的。严格控制血糖可预防糖尿病肾病。控制血压很可能预防绝大多数高血压性肾病。对糖尿病肾病进行检测是有充分依据的。相比之下,对高血压性肾病的筛查则不太明确。在糖尿病方面,大多数已确诊的肾病可通过控制血糖来治疗;对于高血压,则使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂进行血压治疗,并限制饮食中的蛋白质摄入。虽然有人提出了其他治疗靶点,但尚未得到充分确立。未来的研究应集中于确定高危患者、开发更好的风险标志物以及设计更多的治疗方法。

相似文献

1
Prevention of the development and progression of renal disease.预防肾脏疾病的发生和进展。
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S144-7. doi: 10.1097/01.asn.0000070150.60928.06.
2
Antihypertensive treatment and multifactorial approach for renal protection in diabetes.糖尿病肾脏保护的降压治疗及多因素干预方法
J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S18-21. doi: 10.1681/asn.2004110962.
3
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.高血压及其并发症的预防:理论基础与治疗指南
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S92-8. doi: 10.1097/01.asn.0000070142.14843.8e.
4
Remission and regression of diabetic nephropathy.糖尿病肾病的缓解与消退
Curr Hypertens Rep. 2004 Oct;6(5):377-82. doi: 10.1007/s11906-004-0057-x.
5
[Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].[糖尿病肾病能否避免进展至终末期肾功能不全?]
An Med Interna. 1998 Nov;15(11):567-71.
6
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.糖尿病肾病中的血压与肾脏结局:退伍军人事务部糖尿病肾病试验
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19.
7
Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.2型糖尿病早期肾病患者肾功能的保留:初级保健医生与肾病专家的比较前瞻性队列研究
Am J Kidney Dis. 2006 Jan;47(1):78-87. doi: 10.1053/j.ajkd.2005.09.015.
8
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.高血压管理中的治疗争议:糖尿病肾病使用血管紧张素转换酶(ACE)抑制剂还是血管紧张素受体阻滞剂?支持ACE抑制剂的理由。
Ethn Dis. 2002 Fall;12(4):S3-49-52.
9
Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.另一位患有糖尿病肾病自然病程的患者:现状与预防方法
Nefrologia. 2011;31(1):108-10. doi: 10.3265/Nefrologia.pre2010.Oct.10658.
10
[Risk and prevention of diabetic nephropathy].[糖尿病肾病的风险与预防]
G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:13-9.

引用本文的文献

1
Diet and Proteinuria: State of Art.饮食与蛋白尿:现状。
Int J Mol Sci. 2022 Dec 20;24(1):44. doi: 10.3390/ijms24010044.
2
Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.肾功能不全的正常白蛋白尿型糖尿病发病机制和诊断流程的最新进展。
Eur J Med Res. 2021 Dec 11;26(1):144. doi: 10.1186/s40001-021-00612-9.
3
Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea.尿液肾素-血管紧张素系统活性生物标志物:伴有和不伴有阻塞性睡眠呼吸暂停的人类的探索性分析。
Physiol Rep. 2020 Mar;8(6):e14376. doi: 10.14814/phy2.14376.
4
Selective Nanoparticle Targeting of the Renal Tubules.肾小管的选择性纳米颗粒靶向
Hypertension. 2018 Jan;71(1):87-94. doi: 10.1161/HYPERTENSIONAHA.117.09843. Epub 2017 Nov 13.
5
Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes.韩国2型糖尿病患者中非白蛋白尿性肾功能不全的患病率及其与心血管疾病事件的关联
Endocrinol Metab (Seoul). 2016 Dec;31(4):577-585. doi: 10.3803/EnM.2016.31.4.577.
6
Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.2型糖尿病肾病患者循环中微小RNA-126表达降低:一种潜在的血液生物标志物。
Exp Ther Med. 2016 Aug;12(2):815-822. doi: 10.3892/etm.2016.3395. Epub 2016 May 26.
7
Analyses of melatonin, cytokines, and sleep in chronic renal failure.慢性肾衰竭中褪黑素、细胞因子与睡眠的分析
Sleep Breath. 2016 Mar;20(1):339-44. doi: 10.1007/s11325-015-1240-9. Epub 2015 Aug 14.
8
Assessing of the relationship between renal function tests and retinopathy stage in patients with type II diabetes.评估2型糖尿病患者肾功能检查与视网膜病变分期之间的关系。
J Renal Inj Prev. 2015 Mar 1;4(1):11-4. doi: 10.12861/jrip.2015.04. eCollection 2015.
9
Demographic and clinical characteristics of primary glomerular diseases in Turkey.土耳其原发性肾小球疾病的人口统计学和临床特征。
Int Urol Nephrol. 2014 Dec;46(12):2347-55. doi: 10.1007/s11255-014-0838-3. Epub 2014 Sep 30.
10
Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.阿尔巴尼亚2型糖尿病患者微量白蛋白尿患病率及危险因素分析:糖尿病肾病准确早期诊断的必要性
Hippokratia. 2013 Oct;17(4):337-41.